Life ScienceCompany
RVL Pharmaceuticals M&A Summary
RVL Pharmaceuticals has acquired 2 companies. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
It’s largest disclosed sale occurred in 2021, when it sold Osmotica Pharmaceuticals - Legacy Business to Alora Pharmaceuticals for $170M. RVL Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (50%) and life science (50%).
RVL Pharmaceuticals Business Overview
Where is RVL Pharmaceuticals headquartered?
RVL Pharmaceuticals is headquartered in Bridgewater, New Jersey.
What is RVL Pharmaceuticals’ revenue?
RVL Pharmaceuticals disclosed revenue of 240M USD for 2019 and 264M USD for 2018.
How many employees does RVL Pharmaceuticals have?
RVL Pharmaceuticals has 379 employees.
What sector is RVL Pharmaceuticals in?
RVL Pharmaceuticals is a life science company.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity2
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 2
- M&A Advisors 4